October 31, 2020
A larger economic burden is associated with advanced Parkinson disease compared with mild/moderate Parkinson disease, according to a study of Medicare beneficiaries published online in the journal Movement Disorders.
The finding stems from an analysis of fee-for-service Medicare claims from 2013 for 144,703 patients with Parkinson disease. Some 20% of patients in the study had advanced Parkinson’s disease, as determined by a medication-based algorithm.
For all patients in the study, average all-cause costs were $23,041. Average costs from claims with a primary diagnosis of Parkinson disease were $3429, researchers found, while average costs for claims with a Parkinson disease diagnosis in any diagnostic field were $9924.
“Costs varied substantially; any Parkinson disease-related mean costs were $483 for the lowest patient decile (which included 1% of the advanced group) and $48,145 for the highest decile (which included 15% of the advanced group),” researchers wrote.
For advanced Parkinson disease, incremental risk-adjusted costs were $5818 for all-cause costs, $3644 for primary Parkinson disease-related costs, and $6088 for any Parkinson disease-related costs, according to the study.
Dahodwala N, Li P, Jahnke J, et al. Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population [published online ahead of print, 2020 Oct 8]. Mov Disord. 2020;10.1002/mds.28265. doi:10.1002/mds.28265